It was previously shown that in the absence of IFN-α, whether in IFNAR-deficient mice or through the use of IFNAR antibody blockade, autoimmune symptoms of lupus prone mice were improved (77, 78). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.